Article info

PDF
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

Authors

  1. Correspondence to David Mesher, Public Health England, Centre for Infectious Disease Surveillance and Control, 61 Colindale Avenue, London NW9 5EQ, UK; david.mesher{at}phe.gov.uk
View Full Text

Citation

Mesher D, Cuschieri K, Hibbitts S, et al
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

Publication history

  • Received September 16, 2014
  • Revised October 28, 2014
  • Accepted October 30, 2014
  • First published November 19, 2014.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.